4P6-23988-62225
2 vaccinations
5 coded responses
25 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 801 / CO
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-04-03
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
-
2021-04-21
Dose 2 — Pfizer-BioNTech
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: GoodFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
- 2021-05-07
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
-
2021-07-21
Survey response — 3 months, dose 2MedDRA: Anosmia, Cough, Hypogeusia, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Ive had a cold for about 3 weeks that has included full loss of smell and partial loss of taste for about a week and a persistent unresolved cough. COVID test was negative.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-21
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-27
- 2021-10-20
-
2022-04-21
Survey response — 12 months, dose 2MedDRA: COVID-19, Hyposmia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had COVID in January 2022. I experienced symptoms for about 4 weeks. I no longer have consistent ability to smell. I can smell, but the intensity varies and there are times I can barely smell things. This was occurring some prior to having COVID.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): No
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): No
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 9 — 3 months, dose 2
Symptoms: Ive had a cold for about 3 weeks that has included full loss of smell and partial loss of taste for about a week and a persistent unresolved cough. COVID test was negative.
Release 11 — 12 months, dose 2
Symptoms: I had COVID in January 2022. I experienced symptoms for about 4 weeks. I no longer have consistent ability to smell. I can smell, but the intensity varies and there are times I can barely smell things. This was occurring some prior to having COVID. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release